|

Influence of Frailty on Cardiovascular Events and Mortality in Patients With COPD.

RECRUITINGSponsored by Azienda Ospedaliero-Universitaria di Modena
Actively Recruiting
SponsorAzienda Ospedaliero-Universitaria di Modena
Started2024-02-23
Est. completion2025-11-15
Eligibility
Age40 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05922202

Summary

Observational study on the influence of frailty on cardiovascular risk in COPD.

Eligibility

Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients with age ≥18 years, with diagnosis of COPD of at least 1 year, in stable condition, without acute exacerbation in the last 30 days and/or all-cause hospitalisation in the last 3 months
* Smoking history of ≥ 10 pack/years
* Diagnosis of COPD according to GOLD guidelines (www.goldcopd.org)
* Individuals able to provide their written informed consent.

Exclusion Criteria:

* Concurrent diagnosis of interstitial lung disease
* Presence of restrictive pattern on spirometry
* No history of smoking habit
* Individuals not able to provide their written informed consent.

Conditions2

COPDRole of Frailty in COPD

Browse More Trials

COPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.